SEC Filings

Form 6-K
MESOBLAST LTD filed this Form 6-K on 11/07/2018
Document Outline
Entire Document (13676.2 KB)
Subdocument 1 - 6-K - 6-K
Page 1 - UNITED STATES
Page 2 - INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K
Page 3 - SIGNATURES
Page 4 - INDEX TO EXHIBITS
Subdocument 2 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - Appendix 4C
Page 3 - Appendix 4C
Page 4 - Appendix 4C
Page 5 - Appendix 4C
Page 6 - Appendix 4C
Subdocument 3 - EX-99.2 - EX-99.2
Page 1 - Exhibit 99.2
Page 2 - Appendix 4G
Page 3 - Appendix4G
Page 4 - Appendix4G
Page 5 - Appendix4G
Page 6 - Appendix4G
Page 7 - Appendix4G
Page 8 - Appendix4G
Page 9 - Appendix4G
Page 10 - Appendix4G
Page 11 - Appendix4G
Page 12 - CompanyMesoblastBoard
Page 13 - BOARD SUB-COMMITTEES
Page 14 - BOARD PERFORMANCE EVALUATION
Page 15 - INDEPENDENT DIRECTORS
Page 16 - ** Dr Ben-Zion Weiner resigned on 18 June 2018.
Page 17 - CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICER DECLARATION
Page 18 - PRINCIPLE 6.
Page 19 - ECONOMIC, ENVIRONMENTAL AND SOCIAL SUSTAINABILITY
Subdocument 4 - EX-99.3 - EX-99.3
Page 1 - Exhibit 99.3
Page 2 - Mesoblast Limited
Page 3 - That the Company hereby approves, for the purpose of Listing Rule 10.14 and for all other purposes:
Page 4 - services as non-executive directors of the Company, from $1,250,000 per annum to $1,500,000 per annu
Page 5 - Eligibility to Vote
Page 6 - Item 6 Increase in Directors Fees Pool
Page 7 - at least 48 hours prior to the AGM
Page 8 - Mesoblast Limited
Page 9 - Other Current Directorships of Listed Public Companies
Page 10 - Other Current Directorships of Listed Public Companies
Page 11 - Background
Page 12 - The need for shareholder approval
Page 13 - Recommendation
Page 14 - a)NovaQuest Capital Management LLC
Page 15 - Recommendation
Page 16 - Shareholder approval
Page 17 - Effect of provisions proposed to be renewed
Page 18 - The advantages and disadvantages of the proportional bid provisions since their adoption
Page 19 - What are the differences between the existing Constitution and the proposed new Constitution?
Page 20 - N/A
Page 21 - MESOBLAST THE REGENERATIVE MEDICINE COMPANY ABN 68 109 431 870 LODGE YOUR VOTE ONLINE WWW.LINKMARKET
Page 22 - X99999999999 MSB PRX1801D
Subdocument 5 - EX-99.4 - EX-99.4
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A

Share Price ASX: MSB  AUD 1.47 as of Nov 13, 2018